Company Legal Name
Latest Valuation
Founded Year
Headquarter
1X Technologies develops humanoid robots engineered to work collaboratively alongside humans in various operational environments. Founded in 2014 and headquartered in Sunnyvale, Norway, the company focuses on creating advanced robotic systems that can seamlessly integrate into existing workflows and assist with complex tasks requiring human-like dexterity and decision-making capabilities. The company differentiates itself in the competitive robotics market through its emphasis on human-robot collaboration rather than replacement, positioning its solutions as productivity enhancers that augment human capabilities. 1X Technologies' approach centers on developing robots with sophisticated artificial intelligence and mechanical systems that can adapt to dynamic work environments while maintaining safety protocols for human interaction. Currently, the company is advancing its humanoid robot technology with a focus on expanding practical applications across industries where human-robot collaboration can drive operational efficiency. Their ongoing development efforts concentrate on enhancing the robots' autonomous capabilities and refining the intuitive interfaces that enable effective human-machine partnerships in professional settings.
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.




